Navitoclax
那维妥拉
Report date: 2026/03/24 20:00:35
NME
Base Information
Drug NameNavitoclax
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[29]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[32]
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesAbbott Laboratories
China Registration ClassN/A
Develop Information
Inactive CompaniesAbbott LaboratoriesThe Medical College Of Wisconsin NonprofitRutgers University +[4]
Active Indications +[18]
Inactive Indications +[11]